Index of artpub/2022/275789/

Coles, Alasdair J
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis : Benefit/risk following review of trial and post-marketing data
2022
https://ddd.uab.cat/record/275789